Pablo Guzman, MD, FACC

"I am honored to give back to the institution in which I practiced for so many years, and to the community to which I belong."

Chief Medical Officer, Zyversa Therapeutics

Pablo A. Guzman MD, FACC, FSCAI, is Chief Medical Officer for Zyversa Therapeutics, and responsible for reviewing all medical information/research for the company, the design and implementation of clinical trials, and medical affairs. He also chairs the Renal Scientific Advisory Board.

Dr. Guzman earned his medical degree from the University of Puerto Rico School of Medicine and completed his interventional cardiology fellowship at Johns Hopkins University.

A former member of the Holy Cross Medical Group's Cardiology Associates of Fort Lauderdale, Dr. Guzman serves on the Scientific Advisory Board for Therapeutics Solutions International. A fellow of the American College of Cardiology, he brings more than 40 years' clinical experience to the Holy Cross Board's Quality & Safety Committee.